Startups
Tessara Therapeutics Pty Ltd is a regenerative medicine company developing RealBrain® technology to break therapeutic barriers in the biopharmaceutical industry. RealBrain® technology is based on human mimetic 3D neural micro-tissues designed to have high physiological relevance, manufactured at industrial scale for unprecedented reproducibility. Priority applications include a high-throughput drug screening platform that includes a range of models of healthy and diseased brain tissue, and a regenerative medicine platform to develop next generation safe and efficacious tissue therapies for significant unmet neurological medical needs.
Overview
Location
Australia, Victoria, Melbourne
Employees
1-10
Founded date
2018
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 29, 2024 | New Frontiers in Health Research: Tackling Addiction and Intersex Health | In a world where health challenges loom large, two groundbreaking initiatives emerge from the University of Sydney. One aims to tackle the complex web of addiction, while the other seeks to illuminate the often-overlooked health needs of in... |
| Oct 29, 2024 | $3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT | CRC-P GRANT SECURED BY TESSARA THERAPEUTICS, PSYLO, AND THE UNIVERSITY OF SYDNEY TO ADVANCE BRAIN-REWIRING TREATMENTS FOR ADDICTION BOULDER, Colo., Oct. 29, 2024 /PRNewswire/ -- Tessara Therapeutics, Psylo, and the University of Sydney are ... |
| Apr 18, 2024 | Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL" | MELBOURNE, Australia, April 18, 2024 /PRNewswire/ -- Australia's newest biotech incubator Jumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ventures to take up residency in its much-awaited ... |
Reviews 0
FAQ about Tessara Therapeutics
When was Tessara Therapeutics founded?
Tessara Therapeutics was founded in 2018.
What has the press written about Tessara Therapeutics?
Parsers VC has collected 4 articles mentioning Tessara Therapeutics, among them “New Frontiers in Health Research: Tackling Addiction and Intersex Health” (Oct 29, 2024) and “$3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT” (Oct 29, 2024).
Is Tessara Therapeutics still active?
Yes, Tessara Therapeutics is active; its latest activity on Parsers VC dates from Mar 3, 2026.